No conviction changes recorded
Upgrade to premium to see the full reasoning behind each conviction change.
Sign in to unlockFair Value Distribution — percentile bands
0.0% of simulations place fair value above current price
WHAT IS PRICED IN
Revenue-Based Reverse DCF
31.7%/yr
±4.8% · revenue growth to justify current price
FCF-Based Reverse DCF
27.6%/yr
±3.5% · FCF growth to justify current price
THE GAP
Market pricing margin expansion or capex normalization
Upgrade to premium for full distribution data, sensitivity analysis, and segment breakdowns.
Sign in to unlockCurtiss-Wright: defense electronics and industrial/power. Iran war defense spending tailwind. Nuclear power systems for naval and commercial. Tech +4, above both MAs, momentum +0.230.
Smaller defense player vs BWXT/LMT. Industrial segment exposed to manufacturing slowdown. Less diversified than peers.
FY2025: Revenue +12% to $3.50B, ops income +20% to $633M, record backlog $4.08B (+18%). Naval & Power +18%, nuclear I&C = secular tailwind. Clean balance sheet, aggressive buybacks. Raising conviction...
High-quality defense/nuclear compounder. FY2025 record results. 2026 guidance strong ($14.93 EPS midpoint). Valuation stretched at ~$706 — priced for 2030 earnings. Strong watchlist candidate; wait fo...